Paclitaxel Coated Balloons (Optilume) with Dr. Jay Simhan, MD, FACS

Jay Simhan, MD, FACS, explores the role of Paclitaxel-coated balloons, specifically Optum, in treating urethral strictures, focusing on when to proceed, when to hold off, and when to avoid its use. In this 19-minute presentation, Dr. Simhan emphasizes that while the technology offers promise, its application requires careful patient selection. Dr. Simhan discusses concerns about tissue effects, durability, and adverse outcomes. He references the ROBUST III trial, which demonstrates a higher success rate with Optilume than traditional dilation, but points out flaws in the study design, including surgeon awareness of treatment allocation, and trial assessment at six months labeled as one-year results, raising questions about the validity of long-term projections. Patient selection emerges as a critical factor, with the recommendation to consider Optilume primarily for elderly, non-sexually active patients. The presence of Paclitaxel in semen at six months post-procedure raises ethical concerns regarding fertility and teratogenicity, making its use in younger, sexually active men questionable. Dr. Simhan asserts that while Optilume represents a valuable option, it should not be viewed as a universal solution, and its role in urethral reconstruction requires further investigation. Don't forget to join the GRU Community: https://grandroundsinurology.com/regi... Follow us on Twitter/X: https://x.com/GRUrology And like and subscribe to us here on YouTube!